Literature DB >> 18774960

ADAM15 modulates outside-in signalling in chondrocyte-matrix interactions.

Beate B Böhm1, Andrea Schirner2, Harald Burkhardt1.   

Abstract

ADAM15 belongs to a family of transmembrane multi-domain proteins implicated in proteolysis, cell-cell and cell-matrix interactions in various disease conditions. In osteoarthritis (OA), ADAM15 is up-regulated in the chondrocytes already at early stages of cartilage degeneration where it seems to exert homeostatic effects likely associated with its ability to enhance integrin-mediated chondrocyte adhesion to the surrounding collagen matrix. The aim of our present study was, therefore, to characterize functional domains of ADAM15 involved in collagen II (CII) interaction and to analyse associated outside-in signalling events. Accordingly, ADAM15 and respective deletion mutants were stably transfected into the chondrocyte cell line T/C28a4. Transfected cells were adhered to CII and phosphoproteins analysed by Western blotting. Co-immunoprecipitation served to identify protein binding to ADAM15. Our results elucidate the prodomain as critical for the capacity of ADAM15 to enhance CII adhesion, thereby identifying for the first time a cell-adhesive role of a metalloproteinase prodomain. Moreover, the cytoplasmic tail of ADAM15 confers a modulatory effect on the autophosphorylation site Y397 of the focal adhesion kinase (FAK) during chondrocyte-collagen interaction. In conclusion, the newly uncovered impact of ADAM15 on signalling events that arise from chondrocyte interactions with its collagen matrix might contribute to the elucidation of the mechanism underlying its proposed chondroprotective role in degenerative cartilage disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18774960      PMCID: PMC6512361          DOI: 10.1111/j.1582-4934.2008.00490.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  7 in total

1.  ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.

Authors:  Dorothee Fried; Beate B Böhm; Kristin Krause; Harald Burkhardt
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

2.  A microarray analysis of full depth knee cartilage of ovariectomized rats.

Authors:  Anne C Bay-Jensen; Rasmus H Nielsen; Toni Segovia-Silvestre; Moïse Azria; Frank Staedtler; Martin Letzkus; Nicole Hartmann; Arndt H Brachat; Morten A Karsdal
Journal:  BMC Res Notes       Date:  2011-03-15

Review 3.  ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.

Authors:  C-Y Yang; A Chanalaris; L Troeberg
Journal:  Osteoarthritis Cartilage       Date:  2017-02-13       Impact factor: 6.576

4.  Cell adhesion-induced transient interaction of ADAM15 with poly(A) binding protein at the cell membrane colocalizes with mRNA translation.

Authors:  Beate B Böhm; Yuliya Fehrl; Tomasz Janczi; Nadine Schneider; Harald Burkhardt
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

5.  A Disintegrin and Metalloprotease 15 is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and may Mediate Angiogenesis.

Authors:  Shinichiro Nishimi; Takeo Isozaki; Kuninobu Wakabayashi; Hiroko Takeuchi; Tsuyoshi Kasama
Journal:  Cells       Date:  2019-01-09       Impact factor: 6.600

6.  Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage.

Authors:  C Y Yang; A Chanalaris; S Bonelli; O McClurg; G Lorenzatti Hiles; A L Cates; J Miotla Zarebska; T L Vincent; M L Day; S A Müller; S F Lichtenthaler; H Nagase; S D Scilabra; L Troeberg
Journal:  Osteoarthr Cartil Open       Date:  2020-12

7.  A Novel Pro-Inflammatory Mechanosensing Pathway Orchestrated by the Disintegrin Metalloproteinase ADAM15 in Synovial Fibroblasts.

Authors:  Tomasz Janczi; Florian Meier; Yuliya Fehrl; Raimund W Kinne; Beate Böhm; Harald Burkhardt
Journal:  Cells       Date:  2021-10-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.